4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001695028-26-000012
Chief Financial Officer sold 14,000 shares at $13.53 ($189,391)
- Chief Financial Officer acquired 14,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Piscitelli Dominic · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-20 | Exercise or conversion : show line 1 in the form 10b5-1 | +14,000 | $4.36 | $61,040 | 83,828 | D |
| 2026-10-20 | Sale : show line 2 in the form 10b5-1 | −14,000 | $13.53 | $189,391 | 69,828 | D |
| Open-market sales · 14,000 sh · avg $13.53 · $189,391 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-20 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −14,000 | 64,500 | D |
Loading xslF345X06/form4-10212026_091012.xml…